Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
Middha P, Thummalapalli R, Quandt Z, Balaratnam K, Cardenas E, Falcon CJ, Margaret Lung Group P, Gubens MA, Huntsman S, Khan K, Li M, Lovly CM, Patel D, Zhan LJ, Liu G, Aldrich MC, Schoenfeld A, Ziv E. J Immunother Cancer. 2025 Mar 28;13(3):e011273. doi: 10.1136/jitc-2024-011273. PMID: 40154961; PMCID: PMC11956315.
